Zenodo
What treatment options are available for highly proliferative vascular tumors in the temporal bone identified by high Ki-67 and positive markers CD31 and CD34?
By Tripdatabase.
Abstract
Highly proliferative vascular tumors in the temporal bone can be managed through a combination of embolization, surgery, radiation therapy, and chemotherapy, depending on individual patient factors and tumor characteristics.
Keywords
- Vascular Malformations and Hemangiomas
- vascular tumors
- temporal bone
- Ki-67
- CD31
- CD34
- tumor cell proliferation



